Pharmacotherapy Options in Advanced Renal Cell Carcinoma: What Role for Pazopanib?

Bibliographic Details
Main Author: Michael R. Harrison
Format: Article
Language:English
Published: SAGE Publishing 2011-11-01
Series:Clinical Medicine Insights: Oncology
Online Access:http://la-press.com/pharmacotherapy-options-in-advanced-renal-cell-carcinoma-what-role-for-a2903
_version_ 1819010975368478720
author Michael R. Harrison
author_facet Michael R. Harrison
author_sort Michael R. Harrison
collection DOAJ
first_indexed 2024-12-21T01:20:48Z
format Article
id doaj.art-a9667a82325c4d79b95c1dc328318b64
institution Directory Open Access Journal
issn 1179-5549
language English
last_indexed 2024-12-21T01:20:48Z
publishDate 2011-11-01
publisher SAGE Publishing
record_format Article
series Clinical Medicine Insights: Oncology
spelling doaj.art-a9667a82325c4d79b95c1dc328318b642022-12-21T19:20:40ZengSAGE PublishingClinical Medicine Insights: Oncology1179-55492011-11-0120115349364Pharmacotherapy Options in Advanced Renal Cell Carcinoma: What Role for Pazopanib?Michael R. Harrisonhttp://la-press.com/pharmacotherapy-options-in-advanced-renal-cell-carcinoma-what-role-for-a2903
spellingShingle Michael R. Harrison
Pharmacotherapy Options in Advanced Renal Cell Carcinoma: What Role for Pazopanib?
Clinical Medicine Insights: Oncology
title Pharmacotherapy Options in Advanced Renal Cell Carcinoma: What Role for Pazopanib?
title_full Pharmacotherapy Options in Advanced Renal Cell Carcinoma: What Role for Pazopanib?
title_fullStr Pharmacotherapy Options in Advanced Renal Cell Carcinoma: What Role for Pazopanib?
title_full_unstemmed Pharmacotherapy Options in Advanced Renal Cell Carcinoma: What Role for Pazopanib?
title_short Pharmacotherapy Options in Advanced Renal Cell Carcinoma: What Role for Pazopanib?
title_sort pharmacotherapy options in advanced renal cell carcinoma what role for pazopanib
url http://la-press.com/pharmacotherapy-options-in-advanced-renal-cell-carcinoma-what-role-for-a2903
work_keys_str_mv AT michaelrharrison pharmacotherapyoptionsinadvancedrenalcellcarcinomawhatroleforpazopanib